DAILYZ HEALTH NEWS https://validator.w3.org/feed/docs/rss2.html FDA Clears ET-600 for Arginine Vasopressin Deficiency on February 25 PDUFA Date Aggressive Breast Cancer Research Reveals How Tumors Suppress Immune System Genetics Plays Larger Role in Lifespan Than Previously Believed, Weizmann Institute Study Shows New-Onset Anemia Linked To Higher Cancer Risk And Mortality, Study Finds Twice-Yearly Injection Shows Promise For High Blood Pressure Treatment In Global Trial US Measles Total Surpasses 1,714 Cases The Motorcycle Industry as a Case Study in Demographic Failure NATO’s Most Dangerous 65 Kilometers: The Suwalki Gap and the War Already Underway Throttled: The Motorcycle Media That Sells the Lifestyle Is Killing the Market Metformin Mimics Exercise Benefits in Prostate Cancer Patients by Boosting Key Exercise Molecule Production What’s up, Claude? AI Visibility Is Reshaping Digital Strategy — Two Must-Read Reports From Shepherd Gazette’s Tech Desk Healthcare SEO Teams Choose DataForSEO for Privacy-Conscious Search Analytics Researchers Identify How Aggressive Breast Cancer Suppresses Immune System CDC Delays Report on COVID-19 Vaccine Reducing ER Visits and Hospitalizations by Half Zeaxanthin Nutrient from Vegetables Boosts T Cells and Cancer Immunotherapy Efficacy in New Study Gut Bacteria Sugars Trigger Immune Attacks Linked to ALS and Frontotemporal Dementia Mississippi Health Chief Dan Edney Declines CDC Director Nomination Plant Compounds Like Menthol and Capsaicin Target Chronic Inflammation in Diabetes and Cancer Studies Confirm Direct Oral Challenge Safely Delabels Penicillin Allergies in Hospitals Stopping Ozempic or Wegovy Reverses Cardiovascular Benefits, New Study Warns Autism in Adults: Presentation, Diagnosis, and Management UK Biobank Study: Highest Physical Activity Levels Cut Cancer Risk by 26% Across 13 Types Novo Nordisk’s Oral Wegovy Gains FDA Approval, 25mg Semaglutide Tablet Launches for Weight Management Hydrogen Sulfide Gas from CSE Protein Emerges as Potential Alzheimer’s Treatment Target Russian Bots, Kremlin Agitprop, and Meta’s Blind Eye: The Disinformation War Over Hungary’s 2026 Election ASH Highlights PDUFA Dates for Subcutaneous Istuximab in Myeloma, CAR T-Cell Therapy for AML/ALL/MDS Pope Leo XIV’s Good Friday Cross Procession Spotlights Physical Devotion and Spiritual Wellness DNA-Based ‘Smart’ Drug Targets Cancer Cells with Precision, Activates Only on Tumor Markers Congress Enacts Most Favored Nation Pricing for Biologics and Specialty Drugs Amid State Price Controls CMS Finalizes 2.6% Increase in Medicare Hospital Outpatient Payment Rates for CY 2026 Sarcopenic Obesity Combo Raises Death Risk 83%, New Study Warns of Belly Fat and Low Muscle Dangers FDA Proposes Reclassifying Mycobacterium Tuberculosis Immunity Tests to Class II Devices Simple Therapies Outperform Drugs in Major Analysis of 10,000 Knee Arthritis Patients January-February 2026 (vaccine recommendations, oral GLP-1 approvals, appropriations bill) Would either of these alternatives be helpful? Aging Lung Cells Trigger Dangerous Immune Overresponse to Flu and COVID in Older Adults, Study Finds Denali’s Avlayah Reduces CSF Heparan Sulfate by 91% in Phase 1/2 Trial for MPS II FDA Greenlights Avlayah (tividenofusp alfa-eknm) for Hunter Syndrome in Specific Patients on March 24 FDA Approves Icotyde (icotrokinra) for Moderate-to-Severe Plaque Psoriasis in Patients 12 and Older VA Study: Type 2 Diabetes Patients Quitting GLP-1s Face Reversed Weight Loss and Higher Heart Risks Gilead Submits NDA for Bulevirtide, First Potential HDV Treatment, Backed by Phase 3 MYR301 Data FDA Extends Review of Reproxalap for Dry Eye Disease to March 16 Amid Clinical Study Requests Sotyktu (deucravacitinib) Awaits FDA Decision by March 6 for Adults with Active Psoriatic Arthritis FDA Approves Nivolumab Addition to AVD Chemotherapy for Patients 12 and Older with Hodgkin Lymphoma FDA Greenlights Nivolumab Plus AVD Regimen for Untreated Classic Hodgkin Lymphoma in March GSK Resubmits Tebipenem HBr NDA for Complicated UTIs After Phase 3 Non-Inferiority Data FDA Approves Lifyorli (relacorilant) for Platinum-Resistant Ovarian Cancer on March 25 Johnson & Johnson (JNJ) earnings Q1 2024 Fasting-Mimicking Diet Provides Real Relief in New Crohn’s Disease Clinical Trial